Bank Julius Baer & Co. Ltd, Zurich

Bank

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1544599 ZURICH, V8

Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$109,635

-$14,520 QoQ

Shares Held

3,236

-79.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#514

of 671 holders

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bank Julius Baer & Co. Ltd, Zurich holds $50,041,551 across 9 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	4,481,615	$41,813,467
2	NBIX	Neurocrine Biosciences Inc	23,780	$4,007,881
3	UTHR	UNITED THERAPEUTICS Corp	6,050	$3,278,071
4	ZTS	Zoetis Inc.	10,367	$744,972
5	TEVA	Teva Pharmaceutical Industries Ltd This page	3,236	$109,635
6	RDY	Dr Reddys Laboratories Ltd	5,000	$72,450
7	OGI	Organigram Global Inc.	9,838	$10,034
8	TLRY	Tilray Brands, Inc.	977	$4,386

All Filings in TEVA

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$109,635	3,236	-79.1%	Shares	Sole	2026-08-10
2021-12-31	$124,155	15,500	0.0%	Shares	Sole	2022-02-15
2021-09-30	$150,970	15,500	+0.3%	Shares	Sole	2021-11-12
2021-06-30	$153,004	15,455	-0.3%	Shares	Sole	2021-07-23
2021-03-31	$178,870	15,500	-18.3%	Shares	Sole	2021-05-10
2020-12-31	$183,002	18,964	+18.5%	Shares	Sole	2021-02-24
2020-09-30	$144,160	16,000	+33.3%	Shares	Sole	2020-11-10
2020-06-30	$147,960	12,000	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.